XML 37 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
AOCI Attributable to Parent
Balance (in shares) at Dec. 31, 2021     76,143,000      
Balance at Dec. 31, 2021 $ 5,310,607 $ 217,126 $ 76,143 $ 3,045,802 $ 1,864,350 $ 107,186
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of employee common stock options, stock appreciation rights, and related tax benefits (in shares) 15,959   16,000      
Exercise of employee common stock options, stock appreciation rights, and related tax benefits $ 328   $ 16 312    
Dividends, Preferred Stock, Cash (15,192)       (15,192)  
Common dividends paid (68,194)       (68,194)  
Issuance of restricted common shares, net of forfeitures (in shares)     250,000      
Issuance of restricted common shares, net of forfeitures 0   $ 250 (250)    
Restricted shares withheld for taxes & related tax benefit     96,000      
Issuance of restricted common shares, net of forfeitures (5,462)   $ 96 (5,558)    
Restricted shares withheld for taxes (in shares)     (51,000)      
Issuance of restricted common shares, net of forfeitures (5,042)   $ (51) (4,991)    
Stock-based compensation expense 39,552     39,552    
Net income 560,742       560,742  
Other Comprehensive Income (Loss) (297,947)         (297,947)
Balance (in shares) at Dec. 31, 2022     76,454,000      
Balance at Dec. 31, 2022 $ 5,519,392 217,126 $ 76,454 3,074,867 2,341,706 (190,761)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of employee common stock options, stock appreciation rights, and related tax benefits (in shares) 40,188   40,000      
Exercise of employee common stock options, stock appreciation rights, and related tax benefits $ 971   $ 40 931    
Dividends, Preferred Stock, Cash (15,192)       (15,192)  
Common dividends paid (68,737)       (68,737)  
Issuance of restricted common shares, net of forfeitures (in shares)     235,000      
Issuance of restricted common shares, net of forfeitures 0   $ 235 (235)    
Restricted shares withheld for taxes & related tax benefit     97,000      
Issuance of restricted common shares, net of forfeitures (3,725)   $ 97 (3,822)    
Restricted shares withheld for taxes (in shares)     (59,000)      
Issuance of restricted common shares, net of forfeitures (4,186)   $ (59) (4,127)    
Stock-based compensation expense 41,879     41,879    
Net income 562,152       562,152  
Cumulative effect of change in accounting principle [1] (35,002)       (35,002)  
Other Comprehensive Income (Loss) 38,236         38,236
Balance (in shares) at Dec. 31, 2023     76,767,000      
Balance at Dec. 31, 2023 6,035,788 217,126 $ 76,767 3,109,493 2,784,927 (152,525)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends, Preferred Stock, Cash (15,192)       (15,192)  
Common dividends paid (69,014)       (69,014)  
Issuance of restricted common shares, net of forfeitures (in shares)     232,000      
Issuance of restricted common shares, net of forfeitures 0   $ 232 (232)    
Restricted shares withheld for taxes & related tax benefit     311,000      
Issuance of restricted common shares, net of forfeitures (14,430)   $ 311 (14,741)    
Restricted shares withheld for taxes (in shares)     (68,000)      
Issuance of restricted common shares, net of forfeitures (5,842)   $ (68) (5,774)    
Stock-based compensation expense 40,934     40,934    
Net income 475,056       475,056  
Other Comprehensive Income (Loss) (15,419)         (15,419)
Balance (in shares) at Dec. 31, 2024     77,242,000      
Balance at Dec. 31, 2024 $ 6,431,881 $ 217,126 $ 77,242 $ 3,129,680 $ 3,175,777 $ (167,944)
[1] Represents the impact of Banker's Healthcare Group's adoption of ASU 2016-13. See Note 2. Equity Method Investment.